Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,291,786
+$485,148 QoQ
Shares Held
1,077
+22.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,897
of 4,605 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $56,834,770 across 10 Drug Manufacturers - General names. LLY ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
103,992 | $26,410,848 | |
| 2 | NVS |
Novartis AG
|
49,020 | $7,682,414 | |
| 3 | ABBV |
AbbVie Inc.
|
29,986 | $7,545,677 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,965 | $6,549,002 | |
| 5 | AZN |
Astrazeneca PLC
|
32,459 | $6,154,875 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
1,077 | $1,291,786 | |
| 7 | AMGN |
Amgen Inc
|
3,003 | $1,087,446 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,849 | $106,539 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,291,786 | 1,077 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $806,638 | 877 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $648,032 | 603 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $405,153 | 531 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $421,725 | 541 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $447,643 | 542 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $689,396 | 893 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,138,432 | 1,285 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,022,174 | 1,129 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $734,394 | 944 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $246,575 | 423 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $271,250 | 505 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $236,834 | 505 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $169,649 | 494 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $180,724 | 494 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $187,543 | 580 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $188,053 | 580 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $166,094 | 580 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $160,207 | 580 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,931 | 30 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,885 | 30 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,615 | 14 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||